A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study. (Q43106074)
Jump to navigation
Jump to search
scientific article published on 2 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study. |
scientific article published on 2 April 2010 |
Statements
A phase IIIb, multicentre, randomized, double-blind, vehicle-controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study (English)
D Thaçi
J-P Ortonne
S Chimenti
P-D Ghislain
K Kragballe
J-H Saurat
A Khemis
P Sprøgel
H-U Esslinger
K Unnebrink